CONTRALATERAL BREAST-CARCINOMA - RISK AND PROGNOSIS IN T1N0M0 AND T1N1M0 PATIENTS

被引：0
作者：
ROSEN, PP [1 ]
GROSHEN, S [1 ]
HELLMAN, S [1 ]
机构：
[1] MEM HOSP CANC & ALLIED DIS,NEW YORK,NY 10021
来源：
LABORATORY INVESTIGATION | 1989年 / 60卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A79 / A79
页数：1
相关论文
共 50 条
  • [21] Pulmonary adenocarcinoma T1N0M0 and its classification
    Weissferdt, Annikka
    Walsh, Garrett
    Kaiser, Larry
    Moran, Cesar A.
    SEMINARS IN DIAGNOSTIC PATHOLOGY, 2014, 31 (04) : 260 - 264
  • [22] T1N1M0期肾癌治疗进展
    吴恭瑾
    秦泽
    马俊海
    常宏
    岳中瑾
    临床泌尿外科杂志, 2017, 32 (05) : 356 - 360
  • [23] HISTOPATHOLOGIC HIGH-RISK FACTORS INFLUENCING THE PROGNOSIS OF PATIENTS WITH EARLY BREAST-CANCER (T1N0M0)
    BILIK, R
    MOR, C
    WOLLOCH, Y
    DINTSMAN, M
    AMERICAN JOURNAL OF SURGERY, 1986, 151 (04) : 460 - 464
  • [24] EFFECTIVENESS OF SURGICAL AND RADIOTHERAPEUTIC ACTION ON CERVICAL-CARCINOMA, STAGES I AND II (T1N0M0 AND T2N0M0) .1.
    KRAFFT, W
    WAGNER, F
    COTTE, U
    BEHLING, H
    BRUCKMANN, D
    ZENTRALBLATT FUR GYNAKOLOGIE, 1982, 104 (11): : 641 - 649
  • [25] Ductal carcinoma in situ component confers an improved prognosis in early T1N1M0 breast cancer patients.
    Logullo, AF
    Godoy, AB
    Mourao-Neto, M
    Simpson, AJG
    Brentani, MM
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 251 - 251
  • [26] Ukrain therapy of stage T1N0M0 bladder cancer patients
    Uglianitsa, KN
    Nechiporenko, NA
    Nefyodov, LI
    Brzosko, WJ
    DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 1998, 24 (5-6) : 227 - 230
  • [27] TREATMENT OF STAGE-I LUNG-CANCER (T1N0M0, T2N0M0)
    MOORES, DWO
    MCKNEALLY, MF
    SURGICAL CLINICS OF NORTH AMERICA, 1987, 67 (05) : 937 - 943
  • [28] A case of T1N0M0 vulvar apocrine gland carcinoma with a positive outcome
    Ota, Y
    Fukasawa, I
    Shimizu, K
    Okajima, Y
    Inaba, N
    GYNECOLOGIC ONCOLOGY, 2003, 90 (03) : 601 - 604
  • [29] Nutritional and clinical outcomes of chemoradiotherapy for clinical T1N0M0 esophageal carcinoma
    Sakanaka, Katsuyuki
    Fujii, Kota
    Ishida, Yuichi
    Miyamoto, Shin'ichi
    Horimatsu, Takahiro
    Muto, Manabu
    Mizowaki, Takashi
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 3623 - 3630
  • [30] Prospective validation of an institutional treatment strategy for T1N0M0 glottic carcinoma
    Beyaert, Simon
    Hamoir, Marc
    Van Maanen, Aline
    Gregoire, Vincent
    Schmitz, Sandra
    EJSO, 2019, 45 (07): : 1188 - 1195
12345